aTyr Pharma | LIFE - Pre Tax Profit


aTyr Pharma reported $-25.75M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Ardelyx USD -400K 467K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Biogen USD 377.7M 433.7M Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Cipla INR 7.49B 4.2B Mar/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD 19.36M 33.34M Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Grifols EUR 257.85M 190.87M Dec/2024
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Novartis USD 3.84B 802M Mar/2026
Roche Holding CHF 4.79B 3.01B Jun/2025
United Therapeutics USD 444M 6M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024